Header01-REBRAND_MENARINISILICONBIOSYSTEMS

 

Press Releases

12/10/2020

DETECT program studies validate clinical relevance of CTC HER2 phenotypes in metastatic breast cancer patients with HER2 negative primary tumor


Results presented at the 2020 San Antonio Breast Cancer Symposium confirm the relevance of screening for HER2+ CTCs from blood samples in patients with a HER2 negative primary tumor biopsy to optimize treatment strategy and patient outcome

continue →

Topics: CELLSEARCH, metastatic breast cancer, HER2, San Antonio Breast Cancer Symposium, CTC phenotyping

12/9/2020

New Global Pooled Analysis Supports Clinical Utility of Circulating Tumor Cell Count for Early Monitoring of Metastatic Breast Cancer


Robust pooled analysis demonstrating how CTC count may help to optimize treatment choices

continue →

Topics: CELLSEARCH, metastatic breast cancer, global pooled analysis, San Antonio Breast Cancer Symposium

11/9/2020

New Research Study Supports Clinical Utility of Circulating Tumor Cell Count for Metastatic Breast Cancer


First randomized clinical trial demonstrating that CTC count may help personalize treatment choices

continue →

Topics: CELLSEARCH, metastatic breast cancer, STIC

08/4/2020

Two Studies Presented at AACR Meeting Deepen Understanding Of Cancer Mechanisms

Researchers Use Menarini’s Liquid Biopsy Technology to Find Genetic Alterations in Cancer Cells that May Improve Prognosis and Treatment

continue →

Topics: CELLSEARCH, metastatic breast cancer, Multiple myeloma, HER2, AACR

07/13/2020

Menarini Silicon Biosystems Partners with OpGen to Broaden Distribution of CELLSEARCH Platform in North America

Strategic partnership will focus on commercializing CELLSEARCH platform for
COVID-19 related use cases, along with other COVID-19 related products

continue →

Topics: CELLSEARCH, COVID-19, OpGEN

06/11/2020

Menarini Silicon Biosystems Begins Distribution of Rapid COVID-19 Antibody Test in North America

The test detects antibodies made by the immune system in response to infection by the novel coronavirus in as little as 10 minutes

continue →

Topics: COVID-19, Coronavirus, COVID-19 Ab test, SARS-CoV-2, diagnostic

06/10/2020

New ASCO Studies Offer Evidence for Use of Circulating Tumor Cells as a Prognostic Biomarker for Advanced Prostate and Breast Cancer

Results from prospective trials show a "clear prognostic value" for CTC counts

continue →

Topics: CTCs, CELLSEARCH, metastatic breast cancer, prostate cancer, ASCO

04/27/2020

Menarini Silicon Biosystems Explores New Application for Circulating Endothelial Cells in COVID-19

Enumeration of Circulating Endothelial Cells (CECs) with CELLSEARCH platform may offer a new tool for investigating the role of the damaged endothelium in SARS-CoV-2 infection and clinical manifestation.

continue →

Topics: CELLSEARCH, COVID-19, CECs, Coronavirus, Circulating Endothelial Cells

02/28/2020

Menarini Silicon Biosystems to Announce New Solutions for Advancing Liquid Biopsy

Developments for CELLSEARCH and DEPArray Technologies to be Featured at the Molecular Medicine Tri-Conference

continue →

Topics: Liquid biopsy, Precision Medicine, Circulating tumor cells, rare cells

12/10/2019

New Menarini CELLSEARCH Studies to be Presented at San Antonio Breast Cancer Symposium

Northwestern University researchers use gold standard  liquid-biopsy technology to deepen understanding of metastatic breast cancer

continue →

Topics: Liquid biopsy, Precision Medicine, Circulating tumor cells, metastatic breast cancer, rare cells